CHARLES P MEADER
Veterinary in Grover, CO
License number
Massachusetts 1530
Issued Date
Aug 10, 1966
Expiration Date
Feb 28, 2010
Type
Veterinarian
Address
Address
Grover, CO 80729
Professional information
Method Of Production Of Material For Treating Mammalian Joint Maladies By Biological Fluid Transplantation
US Patent:
7547453, Jun 16, 2009
Filed:
Mar 30, 2007
Appl. No.:
11/694331
Inventors:
Charles P. Meader - Grover CO, US
Paul V. Christofferson - Draper UT, US
Paul V. Christofferson - Draper UT, US
Assignee:
Equine Bio-Tech, Inc. - Grover CO
International Classification:
A61K 9/00, A61K 35/12, A61K 35/32
US Classification:
424537, 424520, 424548, 424400
Abstract:
Disclosed is a product and method for transplanting biological fluids into a host animal (including humans) that have been collected from donor animals. These biological fluids have been purified and processed so that they are acellular, sterile, pathogen free, and a form that can be stored for considerable periods of time without degradation. In one embodiment, synovial fluid is harvested from a large number of donors to produce the transplantation compound. Donor fluid is collected from a number of joints per animal, and initially screened for obvious abnormalities (clarity, color, viscosity. . . etc. ) and accepted or rejected on a joint-by-joint basis at the time of collection. The collected fluid is frozen in the field. Once in a laboratory setting, the fluid is warmed and spun down in a centrifuge. The supernate is collected, filtered, and mixed in large batches while the permeate is discarded.
Material For Treating Mammalian Joint Maladies By Biological Fluid Transplantation
US Patent:
7658950, Feb 9, 2010
Filed:
Mar 30, 2007
Appl. No.:
11/694254
Inventors:
Charles P. Meader - Grover CO, US
Paul V. Christofferson - Draper UT, US
Paul V. Christofferson - Draper UT, US
Assignee:
Equine Bio-Tech, Inc. - Grover CO
International Classification:
A61K 9/00, A61K 35/12, A61K 35/32
US Classification:
424537, 424520, 424548, 424400
Abstract:
Disclosed is a product and method for transplanting biological fluids into a host animal (including humans) that have been collected from donor animals. These biological fluids have been purified and processed so that they are acellular, sterile, pathogen free, and a form that can be stored for considerable periods of time without degradation. In one embodiment, synovial fluid is harvested from a large number of donors to produce the transplantation compound. Donor fluid is collected from a number of joints per animal, and initially screened for obvious abnormalities (clarity, color, viscosity. . . etc. ) and accepted or rejected on a joint-by-joint basis at the time of collection. The collected fluid is frozen in the field. Once in a laboratory setting, the fluid is warmed and spun down in a centrifuge. The supernate is collected, filtered, and mixed in large batches while the permeate is discarded.
Method Of Treating Mammalian Joint Maladies By Biological Fluid Transplantation
US Patent:
2006008, Apr 20, 2006
Filed:
Dec 3, 2003
Appl. No.:
10/727893
Inventors:
Charles Meader - Grover CO, US
Paul Christofferson - Draper UT, US
Paul Christofferson - Draper UT, US
International Classification:
A61K 35/12
US Classification:
424520000
Abstract:
Disclosed is a product and method for transplanting biological fluids into a host animal (including humans) that have been collected from donor animals. These biological fluids have been purified and processed so that they are a cellular, sterile, pathogen free, and a form that can be stored for considerable periods of time without degradation. In one embodiment, synovial fluid is harvested from a large number of donors to produce the transplantation compound. Donor fluid is collected from a number of joints per animal, and initially screened for obvious abnormalities (clarity, color, viscosity. . . etc.) and accepted or rejected on a joint-by-joint basis at the time of collection. The collected fluid is frozen in the field. Once in a laboratory setting, the fluid is warmed and spun down in a centrifuge. The supernate is collected, filtered, and mixed in large batches while the permeate is discarded. The supernate is re-frozen, lyophilized (freeze-dried) to form a cake and packaged as an individual dose under vacuum. The product is sterile, stable, has a long shelf life and can be readily reconstituted and injected into a joint.